155 related articles for article (PubMed ID: 32284205)
1. [A case of systemic sclerosis].
Taieb D; Chauveau S; Khamis W; de Montmollin N; Sesé L; Duchemann B; Nunes H; Uzunhan Y
Rev Mal Respir; 2020 Apr; 37(4):341-345. PubMed ID: 32284205
[TBL] [Abstract][Full Text] [Related]
2. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
[TBL] [Abstract][Full Text] [Related]
3. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis in the absence of skin disease.
Bhavsar SV; Carmona R
J Clin Rheumatol; 2014 Oct; 20(7):379-82. PubMed ID: 25275766
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of systemic sclerosis patients with anti-RNA polymerase III antibody in a single centre in Spain.
Callejas-Moraga EL; Guillén-Del-Castillo A; Marín-Sánchez AM; Roca-Herrera M; Balada E; Tolosa-Vilella C; Fonollosa-Pla V; Simeón-Aznar CP
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):41-48. PubMed ID: 30767873
[TBL] [Abstract][Full Text] [Related]
5. Diffuse alveolar haemorrhage in a case with anti-RNA polymerase III antibody-positive systemic sclerosis successfully treated with plasma exchange and corticosteroid therapy.
Asai A; Banno S; Asai N; Ito M; Sugiyama H; Yamaguchi M; Iwagaitsu S; Nobata H; Kinasi H; Katsuno T; Ito Y
Mod Rheumatol Case Rep; 2020 Jan; 4(1):51-55. PubMed ID: 33086969
[TBL] [Abstract][Full Text] [Related]
6. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
7. [Cancers associated with systemic sclerosis involving anti-RNA polymerase III antibodies].
Monfort JB; Mathian A; Amoura Z; Francès C; Barbaud A; Senet P
Ann Dermatol Venereol; 2018 Jan; 145(1):33-36. PubMed ID: 28917576
[TBL] [Abstract][Full Text] [Related]
8. Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.
Lazzaroni MG; Cavazzana I; Colombo E; Dobrota R; Hernandez J; Hesselstrand R; Varju C; Nagy G; Smith V; Caramaschi P; Riccieri V; Hachulla E; Balbir-Gurman A; Chatelus E; Romanowska-Próchnicka K; Araújo AC; Distler O; Allanore Y; Airò P;
J Rheumatol; 2017 May; 44(5):639-647. PubMed ID: 28089973
[TBL] [Abstract][Full Text] [Related]
9. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
Meyer O; De Chaisemartin L; Nicaise-Roland P; Cabane J; Tubach F; Dieude P; Hayem G; Palazzo E; Chollet-Martin S; Kahan A; Allanore Y
J Rheumatol; 2010 Jan; 37(1):125-30. PubMed ID: 19918031
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological, clinical and evolutionary peculiarities of interstitial lung disease in systemic sclerosis].
Aydi Z; Rachdi I; Ben Dhaou B; Dridi M; Daoud F; Baili L; Boussema F
Rev Pneumol Clin; 2016 Apr; 72(2):122-8. PubMed ID: 26651932
[TBL] [Abstract][Full Text] [Related]
11. Systemic Sclerosis and Pulmonary Disease.
Ngo K
Adv Exp Med Biol; 2021; 1303():173-182. PubMed ID: 33788193
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Systemic Sclerosis patients with positive anti-Th/To antibodies: About 6 patients and literature review.
Muller R; Benyamine A; Bertin D; Harlé JR; Kaplanski G; Mazodier K; Reynaud-Gaubert M; Granel B; Bardin N
Rev Med Interne; 2020 Jul; 41(7):440-445. PubMed ID: 32063422
[TBL] [Abstract][Full Text] [Related]
13. [Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?].
Hachulla E
Rev Med Interne; 2019 Dec; 40(12):775-777. PubMed ID: 31477468
[No Abstract] [Full Text] [Related]
14. Anti-RNA polymerase III antibody-associated scleroderma renal crisis in a patient with limited cutaneous systemic sclerosis: A case report.
Takada D; Hoshino J; Kikuchi K; Yabuuchi J; Kogure Y; Ueno T; Sekine A; Yamanouchi M; Sumida K; Mise K; Suwabe T; Hayami N; Sawa N; Takaichi K; Hayasi N; Fujii T; Ohashi K; Ubara Y
Mod Rheumatol; 2018 Mar; 28(2):369-372. PubMed ID: 26942857
[TBL] [Abstract][Full Text] [Related]
15. An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis.
Yayla ME; İlgen U; Düzgün N
Turk J Med Sci; 2018 Feb; 48(1):10-15. PubMed ID: 29479936
[TBL] [Abstract][Full Text] [Related]
16. A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.
Kang EH; Im CH; Kim SH; Chung JR; Lee EY; Kim DJ; Lee EB; Song YW
J Korean Med Sci; 2006 Dec; 21(6):1121-3. PubMed ID: 17179700
[TBL] [Abstract][Full Text] [Related]
17. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
Girard C; Vincent T; Bessis D
Ann Dermatol Venereol; 2013 Oct; 140(10):628-34. PubMed ID: 24090894
[TBL] [Abstract][Full Text] [Related]
18. Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?
Diot E; Giraudeau B; Diot P; Degenne D; Ritz L; Guilmot JL; Lemarié E
Chest; 1999 Sep; 116(3):715-20. PubMed ID: 10492277
[TBL] [Abstract][Full Text] [Related]
19. Late onset systemic sclerosis with seronegativity: a rare presentation of an uncommon disease.
Saxena D; Jain D; Yadav M; Giri K; Yadav T; Jain P
Reumatismo; 2019 Oct; 71(3):166-170. PubMed ID: 31649382
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis-associated interstitial lung disease.
Perelas A; Silver RM; Arrossi AV; Highland KB
Lancet Respir Med; 2020 Mar; 8(3):304-320. PubMed ID: 32113575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
